Tue, May 20, 8:07 PM (33 days ago)
**Bodhi Tree Biotechnology Inc. (BOTI) Q1 2025 Financial Summary** **Financial Health and Performance:** - **Revenue:** $5,000 for Q1 2025, up from $0 in Q1 2024. - **Net Loss:** $53,428 for Q1 2025, compared to $116 in Q1 2024. - **Cash Position:** $144,165 as of March 31, 2025, down from $259,570 at the end of Q4 2024. - **Profit Margins:** Negative, with significant operating losses. - **Cash Flow:** Negative cash flow from operations at $115,405 for the six months ended March 31, 2025. **Key Metrics and Trends:** - **Operational Expenses:** $52,179 in general and administrative expenses for Q1 2025, primarily due to professional services. - **Revenue Concentration:** 100% of revenue came from a single customer in Q1 2025, indicating high risk. - **Cash Burn:** Significant cash burn rate, with negative cash flow from operations. **Management Discussion:** - **Future Operations:** Plans to fund operations through public offerings, private placements, or stock issuance until profitable. - **Liquidity:** Dependence on external funding to maintain operations. - **Internal Controls:** Material weaknesses identified in internal controls over financial reporting, with plans to improve. **Uncertainties and Risks:** - **Funding:** Uncertainty in securing additional funding. - **Market Risk:** Dependence on a single customer for revenue. - **Operational Risks:** High operational expenses relative to revenue. **Future Impact:** - **Growth Strategy:** Focus on expanding customer base and reducing operational costs. - **Financial Strategy:** Seeking additional funding to sustain operations and achieve profitability. **Conclusion:** Bodhi Tree Biotechnology Inc. faces significant financial challenges, including high operational costs, negative cash flow, and dependence on a single customer. The company is actively seeking additional funding and improving internal controls to mitigate risks and support future growth.